The Chronic Cough market in North America is expected to grow from US$ 2,118.42 million in 2019 to US$ 3,944.89 million by 2027. This represents a CAGR of 8.1% from 2020 to 2027.
The growth of the market in the region is expected to grow owing to rising incidences of chronic cough, growing product developments to treat chronic cough. Additionally, robust product pipeline, presence of major players and well-developed regulatory policies are projected to drive the North American chronic cough market during the forecast period. The US has observed fast growth in the chronic cough market within the past few years and is expected to lead the market in North America during the forecast period. Chronic cough is defined as a persistent cough that lasts long up to 6-8 weeks. It significantly affects the life of the patients by interrupt sleeping, vomiting, light-headedness, and even rib fractures. It is caused due to multiple reasons such as infections, asthma, gastro esophageal reflux disease (GERD), among others. Additionally, , the government initiatives for the treatment, diagnosis and awareness program will further propel the growth in the country. For instance, The Temple Lung Center’s Chronic Cough Program team specializes in finding the cause of your chronic cough and can offer treatments to lessen the cough or address the underlying medical condition. In addition, The Global Initiative for Chronic Obstructive Lung Disease (GOLD) works with health care professionals and public health officials around the world to raise awareness of Chronic Obstructive Pulmonary Disease (COPD) and to improve prevention and treatment of this lung disease.
US Chronic Cough Market Revenue and Forecast to 2027 (US$ Million)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
NORTH AMERICA CHRONIC COUGH – MARKET SEGMENTATION
By Drug Class
- Antihistamines
- Corticosteroids
- Decongestants
- Combination Drug
- Antibiotics
- Acid Blockers
- Other Drug Class
By Route of Administration
- Oral
- Injections
- Nasal
- Other Route of Administration
By Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
By Country
- US
- Canada
- Mexico
Company Profiles
- Novartis AG
- Teva Pharmaceutical Industries Ltd
- GlaxoSmithKline plc.
- Bayer AG
- Mylan N.V.
- Amneal Pharmaceuticals, Inc.
- Cipla Inc.
- Reckitt Benckiser Group plc.
- Sun Pharmaceutical Industries Ltd
- Aurobindo Pharma Ltd
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Drug Class, Route of Administration, Distribution Channel, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Chronic Cough Market – By Drug Class
1.3.2 Chronic Cough Market – By Route of Administration
1.3.3 Chronic Cough Market – By Distribution Channel
1.3.4 North America Chronic Cough Market – By Country
2. Chronic Cough Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Chronic Cough Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Expert Opinion
5. Chronic Cough Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidences of Chronic Cough
5.1.2 Growing Product Developments to Treat Chronic Cough
5.2 Market Restraints
5.2.1 Product Recalls
5.3 Market Opportunities
5.3.1 Aging Population is Expected to Drive Demand for Chronic Cough Treatment
5.4 Future Trends
5.4.1 Continuous Trend of Drug Development
5.5 Impact Analysis
6. Chronic Cough Market Analysis – By Drug Class
6.1 Overview
6.2 Chronic Cough Market Revenue Share, by Drug Class (2019 and 2027)
6.3 Antihistamines
6.3.1 Overview
6.3.2 Antihistamines: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
6.4 Corticosteroids
6.4.1 Overview
6.4.2 Corticosteroids: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
6.5 Decongestants
6.5.1 Overview
6.5.2 Decongestants: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
6.6 Combination Drug
6.6.1 Overview
6.6.2 Combination Drug: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
6.7 Antibiotics
6.7.1 Overview
6.7.2 Antibiotics: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
6.8 Acid Blockers
6.8.1 Overview
6.8.2 Acid Blockers: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
6.9 Other Drug Class
6.9.1 Overview
6.9.2 Other Drug Class: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
7. Chronic Cough Market – By Route of Administration
7.1 Overview
7.2 Chronic Cough Market, by Route of Administration, 2019 and 2027 (%)
7.3 Oral
7.3.1 Overview
7.3.2 Oral: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Injections
7.4.1 Overview
7.4.2 Injections: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Inhalation
7.5.1 Overview
7.5.2 Inhalation: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Other Route of Administration
7.6.1 Overview
7.6.2 Other Route of Administration: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
8. Chronic Cough Market – By Distribution Channel
8.1 Overview
8.2 Chronic Cough Market, by Distribution Channel, 2019 and 2027 (%)
8.3 Hospital Pharmacy
8.3.1 Overview
8.3.2 Hospital Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Online Pharmacy
8.4.1 Overview
8.4.2 Online Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Retail Pharmacy
8.5.1 Overview
8.5.2 Retail Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
9. Chronic Cough Market – Regional Analysis
9.1 North America Chronic Cough Market
9.1.1 Overview
9.1.2 North America: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)
9.1.3 North America: Chronic Cough Market, by Drug Class, 2018–2027 (USD Million)
9.1.4 North America: Chronic Cough Market, by Route of Administration , 2018–2027 (USD Million)
9.1.5 North America: Chronic Cough Market, by Distribution Channel , 2018–2027 (USD Million)
9.1.6 North America: Chronic Cough Market, by Country, 2019 & 2027 (%)
9.1.7 US: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 US: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 US: Chronic Cough Market, by Drug Class, 2018–2027 (USD Million)
9.1.7.3 US: Chronic Cough Market, by Route of Administration , 2018–2027 (USD Million)
9.1.7.4 US: Chronic Cough Market, by Distribution Channel , 2018–2027 (USD Million)
9.1.8 Canada: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Canada: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Canada: Chronic Cough Market, by Drug Class, 2018–2027 (USD Million)
9.1.8.3 Canada: Chronic Cough Market, by Route of Administration , 2018–2027 (USD Million)
9.1.8.4 Canada: Chronic Cough Market, by Distribution Channel , 2018–2027 (USD Million)
9.1.9 Mexico: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)
9.1.9.1 Mexico: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)
9.1.9.2 Mexico: Chronic Cough Market, by Drug Class, 2018–2027 (USD Million)
9.1.9.3 Mexico: Chronic Cough Market, by Route of Administration , 2018–2027 (USD Million)
9.1.9.4 Mexico: Chronic Cough Market, by Distribution Channel , 2018–2027 (USD Million)
10. Impact of COVID-19 Pandemic on North America Chronic cough Market
10.1 Impact Assessment of COVID-19 Pandemic
11. COMPANY PROFILES
11.1 Novartis AG
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 TEVA PHARMACEUTICAL INDUSTRIES LTD
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 GlaxoSmithKline plc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Bayer AG
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 MYLAN N.V.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Amneal Pharmaceuticals, Inc.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Cipla Inc.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Reckitt Benckiser Group plc.
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Sun Pharmaceutical Industries Ltd
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Aurobindo Pharma Ltd
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 Glossary of Terms
LIST OF TABLES
Table 1. North America Chronic Cough Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 2. North America Chronic Cough Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)
Table 3. North America Chronic Cough Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 4. US Chronic Cough Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 5. US Chronic Cough Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)
Table 6. US Chronic Cough Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 7. Canada Chronic Cough Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 8. Canada Chronic Cough Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Chronic Cough Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 10. Mexico Chronic Cough Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 11. Mexico Chronic Cough Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)
Table 12. Mexico Chronic Cough Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 13. Glossary of Terms, Chronic Cough Market
LIST OF FIGURES
Figure 1. Chronic Cough Market Segmentation
Figure 2. Chronic Cough Market – By Geography
Figure 3. North America Chronic Cough Market Overview
Figure 4. Combination Drug Segment Held Largest Share of Chronic Cough Market
Figure 5. US to Show Remarkable Growth During Forecast Period
Figure 6. PEST Analysis
Figure 7. Expert Opinion
Figure 8. Chronic Cough Market Impact Analysis of Drivers and Restraints
Figure 9. Chronic Cough Market Revenue Share, by Drug Class (2019 and 2027)
Figure 10. Antihistamines: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Corticosteroids: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Decongestants: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Combination Drug: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Antibiotics: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Acid Blockers: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Other Drug Class: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Chronic Cough Market, by Route of Administration, 2019 and 2027 (%)
Figure 18. Oral: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Injections: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Inhalation: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Other Route of Administration: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Chronic Cough Market, by Distribution Channel, 2019 and 2027 (%)
Figure 23. Hospital Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Online Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Retail Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. North America: Chronic Cough Market, by Key Country – Revenue (2019) (USD Million)
Figure 27. North America Chronic Cough Market Revenue and Forecast to 2027 (USD Million)
Figure 28. North America: Chronic Cough Market, by Country, 2019 & 2027 (%)
Figure 29. US: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. Canada: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Mexico: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)
Figure 32. Impact of COVID-19 Pandemic in North American Country Markets
- Novartis AG
- Teva Pharmaceutical Industries Ltd
- GlaxoSmithKline plc.
- Bayer AG
- Mylan N.V.
- Amneal Pharmaceuticals, Inc.
- Cipla Inc.
- Reckitt Benckiser Group plc.
- Sun Pharmaceutical Industries Ltd
- Aurobindo Pharma Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to North America Chronic Cough Market
Aug 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Aug 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Aug 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Aug 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Aug 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)